id	sid	eid	entity	type
dti-1367	1	1	11	CARDINAL
dti-1367	1	2	1–3	CARDINAL
dti-1367	1	3	2017	CARDINAL
dti-1367	2	1	10.1177/1177392817737515	CARDINAL
dti-1367	2	2	4.0	CARDINAL
dti-1367	3	1	march 2017	DATE
dti-1367	3	2	the food and drug administration	ORG
dti-1367	3	3	fda	ORG
dti-1367	4	1	anti-cd20	NORP
dti-1367	5	1	rtx	ORG
dti-1367	5	2	cd20 molecule1	PERSON
dti-1367	6	1	fda	ORG
dti-1367	6	2	2006	DATE
dti-1367	6	3	first	ORDINAL
dti-1367	7	1	neuromyelitis optica	ORG
dti-1367	7	2	antimyelin	ORG
dti-1367	7	3	anti-cd20	NORP
dti-1367	8	1	cd20	PRODUCT
dti-1367	9	1	cd19	PRODUCT
dti-1367	9	2	cd20	PRODUCT
dti-1367	9	3	cd20	PRODUCT
dti-1367	9	4	cells.2–3	ORG
dti-1367	9	5	cd20	PRODUCT
dti-1367	9	6	cd19	PRODUCT
dti-1367	9	7	cd19	PRODUCT
dti-1367	10	1	cd20	PRODUCT
dti-1367	10	2	cd20	PRODUCT
dti-1367	10	3	cd19	PRODUCT
dti-1367	10	4	anti-cd20	NORP
dti-1367	11	1	between 9 and 12 months	DATE
dti-1367	11	2	cd19	PRODUCT
dti-1367	11	3	20	CARDINAL
dti-1367	11	4	2 weeks	DATE
dti-1367	11	5	first	ORDINAL
dti-1367	12	1	at least 6 months	DATE
dti-1367	13	1	more than 3 years	DATE
dti-1367	13	2	rtx	ORG
dti-1367	14	1	6-month	DATE
dti-1367	15	1	8 months	DATE
dti-1367	15	2	anti-cd20	PERSON
dti-1367	16	1	1department	CARDINAL
dti-1367	16	2	greenville	GPE
dti-1367	16	3	greenville	GPE
dti-1367	16	4	sc, usa	ORG
dti-1367	17	1	2department	CARDINAL
dti-1367	17	2	greenville	GPE
dti-1367	17	3	sc	GPE
dti-1367	17	4	usa.	GPE
dti-1367	17	5	20	CARDINAL
dti-1367	18	1	genentech	ORG
dti-1367	18	2	genentech	ORG
dti-1367	18	3	cd20	PRODUCT
dti-1367	19	1	anti-cd20	NORP
dti-1367	20	1	cd20	PRODUCT
dti-1367	21	1	every 6 months	DATE
dti-1367	21	2	cd20	PRODUCT
dti-1367	22	1	cd19	PRODUCT
dti-1367	22	2	cd20	PRODUCT
dti-1367	22	3	monthly	DATE
dti-1367	23	1	ocrelizumab	PERSON
dti-1367	23	2	cd19/20	GPE
dti-1367	23	3	june 30, 2017	DATE
dti-1367	24	1	september 4, 2017	DATE
dti-1367	25	1	two	CARDINAL
dti-1367	26	1	230	CARDINAL
dti-1367	29	1	jagannadha avasarala	PERSON
dti-1367	29	2	greenville	GPE
dti-1367	29	3	29615	DATE
dti-1367	29	4	usa.	GPE
dti-1367	29	5	javasarala@ghs.org 737515	PERSON
dti-1367	29	6	2	CARDINAL
dti-1367	29	7	107	CARDINAL
dti-1367	29	8	105 (	PERCENT
dti-1367	29	9	98.1%	PERCENT
dti-1367	29	10	at least 1	CARDINAL
dti-1367	29	11	cd20	PRODUCT
dti-1367	29	12	first	ORDINAL
dti-1367	29	13	138.3 ±	CARDINAL
dti-1367	29	14	121.4 days	DATE
dti-1367	29	15	cd20	PRODUCT
dti-1367	29	16	1000 mg	QUANTITY
dti-1367	29	17	1000 mg	QUANTITY
dti-1367	29	18	2 weeks later	DATE
dti-1367	29	19	0	CARDINAL
dti-1367	29	20	6 months	DATE
dti-1367	29	21	20%	PERCENT
dti-1367	29	22	3%	PERCENT
dti-1367	29	23	cd20	PRODUCT
dti-1367	29	24	above 2%	PERCENT
dti-1367	30	1	20%	PERCENT
dti-1367	30	2	cd20	PRODUCT
dti-1367	30	3	0	CARDINAL
dti-1367	30	4	6 months	DATE
dti-1367	30	5	5%	PERCENT
dti-1367	30	6	2%	PERCENT
dti-1367	30	7	6 months	DATE
dti-1367	31	1	one	CARDINAL
dti-1367	31	2	cd20	PRODUCT
dti-1367	33	1	cd20	PRODUCT
dti-1367	33	2	less than 20	CARDINAL
dti-1367	36	1	rtx	ORG
dti-1367	36	2	6 to 9 months	DATE
dti-1367	37	1	greenberg	PERSON
dti-1367	37	2	colleagues9	PERSON
dti-1367	37	3	cd20	PRODUCT
dti-1367	38	1	nmo	ORG
dti-1367	38	2	every 69 months	DATE
dti-1367	38	3	rtx	ORG
dti-1367	38	4	cd20	PRODUCT
dti-1367	38	5	rtx	ORG
dti-1367	39	1	rtx	ORG
dti-1367	39	2	1	CARDINAL
dti-1367	39	3	2	CARDINAL
dti-1367	39	4	every 24 weeks	DATE
dti-1367	41	1	6-month	DATE
dti-1367	42	1	cd20	PRODUCT
dti-1367	42	2	cd19	PRODUCT
dti-1367	42	3	cd20	PRODUCT
dti-1367	43	1	up to 1%	PERCENT
dti-1367	43	2	12/1311	CARDINAL
dti-1367	43	3	adas	ORG
dti-1367	43	4	2	CARDINAL
dti-1367	44	1	one	CARDINAL
dti-1367	44	2	cd20	PRODUCT
dti-1367	45	1	1	CARDINAL
dti-1367	45	2	2	CARDINAL
dti-1367	45	3	cd19	PRODUCT
dti-1367	45	4	20	CARDINAL
dti-1367	45	5	24 weeks	DATE
dti-1367	46	1	biopharmaceutics	ORG
dti-1367	48	1	fda	ORG
dti-1367	49	1	one	CARDINAL
dti-1367	49	2	at least 5 months	DATE
dti-1367	50	1	cd20	PRODUCT
dti-1367	50	2	6 months	DATE
dti-1367	51	1	monthly	DATE
dti-1367	51	2	cd19	PRODUCT
dti-1367	53	1	1	CARDINAL
dti-1367	54	1	act2847	PRODUCT
dti-1367	54	2	avasarala 3	DATE
dti-1367	55	1	cd20	PRODUCT
dti-1367	55	2	20	CARDINAL
dti-1367	56	1	third	ORDINAL
dti-1367	58	1	1	CARDINAL
dti-1367	58	2	monthly	DATE
dti-1367	58	3	cd20	PRODUCT
dti-1367	58	4	cd19	PRODUCT
dti-1367	59	1	2	CARDINAL
dti-1367	59	2	cd20	PRODUCT
dti-1367	59	3	monthly	DATE
dti-1367	59	4	adas	PERSON
dti-1367	59	5	cd19	PRODUCT
dti-1367	61	1	1	CARDINAL
dti-1367	63	1	nat rev drug discov	PERSON
dti-1367	64	1	2006;5:564–576	CARDINAL
dti-1367	65	1	2	CARDINAL
dti-1367	65	2	edwards jc	PERSON
dti-1367	65	3	cambridge g.	PERSON
dti-1367	67	1	oxford	NORP
dti-1367	68	1	2005;44:151–156	CARDINAL
dti-1367	69	1	3	CARDINAL
dti-1367	69	2	hoyer bf	PERSON
dti-1367	69	3	f. long-	PERSON
dti-1367	70	1	ann n y acad sci	PERSON
dti-1367	70	2	2005;1050:124–133	CARDINAL
dti-1367	71	1	4	CARDINAL
dti-1367	71	2	kennedy	PERSON
dti-1367	71	3	williams	PERSON
dti-1367	71	4	taylor rp	PERSON
dti-1367	72	1	thp-1	ORG
dti-1367	73	1	j immunol	PERSON
dti-1367	74	1	2006;176:2600–2609	CARDINAL
dti-1367	75	1	5	CARDINAL
dti-1367	75	2	pedersen ae	PERSON
dti-1367	75	3	jungersen mb	PERSON
dti-1367	75	4	pedersen	PERSON
dti-1367	75	5	anti-cd20	NORP
dti-1367	77	1	2011;133:239–245	CARDINAL
dti-1367	78	1	dass s	PERSON
dti-1367	78	2	rawstron ac	PERSON
dti-1367	78	3	henshaw k	PERSON
dti-1367	80	1	2008;58:2993–2999	CARDINAL
dti-1367	81	1	7	CARDINAL
dti-1367	81	2	leandro mj	PERSON
dti-1367	81	3	cambridge g	PERSON
dti-1367	81	4	edwards jc.	PERSON
dti-1367	83	1	2006;54:613–620	CARDINAL
dti-1367	84	1	8	CARDINAL
dti-1367	84	2	barra	PERSON
dti-1367	84	3	huy vo k	ORG
dti-1367	85	1	stankiewicz jm	ORG
dti-1367	85	2	october 9	DATE
dti-1367	85	3	2016	DATE
dti-1367	86	1	j exp transl	PERSON
dti-1367	87	1	2055217316672100	DATE
dti-1367	88	1	9	CARDINAL
dti-1367	88	2	jacob a	PERSON
dti-1367	88	3	violich	PERSON
dti-1367	89	1	25	CARDINAL
dti-1367	91	1	2008;65	CARDINAL
dti-1367	91	2	1443–1448	CARDINAL
dti-1367	91	3	10	CARDINAL
dti-1367	92	1	greenberg bm	PERSON
dti-1367	92	2	remington g	PERSON
dti-1367	92	3	rituximab	PERSON
dti-1367	93	1	j. 2012;18:1022–1026	PERSON
dti-1367	94	1	11	CARDINAL
dti-1367	95	1	pellkofer hl	PERSON
dti-1367	98	1	neurol	GPE
dti-1367	99	1	2011;76:1310–1315	CARDINAL
dti-1367	100	1	12	CARDINAL
dti-1367	101	1	rituximab	PERSON
dti-1367	101	2	cd20	PRODUCT
dti-1367	103	1	2014;193:580–586	CARDINAL
dti-1367	104	1	2	CARDINAL
dti-1367	105	1	wa25046	DATE